本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

23.89
+0.50502.16%
盤後23.890.00000.00%19:30 EDT
成交量:204.47萬
成交額:4,889.38萬
市值:29.87億
市盈率:110.88
高:24.18
開:23.63
低:23.55
收:23.38
52周最高:31.77
52周最低:16.57
股本:1.25億
流通股本:1.11億
量比:0.90
換手率:1.84%
股息:- -
股息率:- -
每股收益(TTM):0.2154
每股收益(LYR):-0.1269
淨資產收益率:15.86%
總資產收益率:5.09%
市淨率:13.54
市盈率(LYR):-188.28

資料載入中...

2026/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/17

重要事件披露

Form 8-K - Current report
2026/07/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

重要事件披露

Form 8-K - Current report
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors